Wen Dombrowski, MD, MBA, Resonate Health LLC, said that it’s important to develop health information technologies because the lack thereof not only impacts the individual living with the condition, but the entire environment and community he or she may live in.
Wen Dombrowski, MD, MBA, Resonate Health LLC, said that it’s important to develop health information technologies because the lack thereof not only impacts the individual living with the condition, but the entire environment and community he or she may live in.
Transcript (slightly modified)
Why is it important to utilize and develop the health technology available among physician and care providers?
It’s really important to develop the technologies and to not just stand at a status quo because really at the end of the day, patient’s lives are at stake. And, a lot of these decisions are life and death, and even when it’s not a life and death level, the quality of life of individuals is at stake. So is the impact on the family members and the coworkers and friends and neighbors around them.
So for example, I have friends and patients that have chronic pain and because they don’t have a good network of providers taking care of them and the providers don’t have all the information about them, they’re really not getting the optimal care that they could really use. And every day, these individuals are suffering from pain and all of their family members are suffering because they’re loved one is in pain. And there’s a ripple effect on society within the family unit and within workplaces and communities. When 1 person is not feeling well or not at their optimal physical or mental health, then it really has a public health impact on a broader scale.
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More